Neonatal Respiratory Distress Syndrome Market to Develop Rapidly by 2020

Neonatal respiratory distress syndrome, also referred to as infant respiratory distress syndrome is characterized by a particular condition often observed in premature babies, usually born about six weeks before their due dates. During this condition, lungs of the premature infants lose the ability to produce enough surfactants in order to provide oxygen to the body. Surfactants are liquids made up of fat and proteins and it helps the lungs to remain inflated so that infants can breathe in and out immediately after their birth. Hence, the prime cause for the prevalence of neonatal respiratory distress syndrome is the lack of surfactant in the lungs.

symptoms associated with neonatal respiratory distress syndrome are Grunting respiration, Flaring nostrils, Cyanosis, Blue-colored lips, fingers and toes, Sharp pulling in the chest, Rapid breathing.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2971

Based on geography, the Neonatal Respiratory Distress Syndrome Market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World. Out of these regions, North America dominates the neonatal respiratory distress market followed by Europe. The prime reasons which have driven the growth of this market in these regions are high prevalence of respiratory disorders in infants and increasing genetic problems with lung development. According to a survey, neonatal respiratory distress syndrome is estimated to affect around 20,000-30,000 infants each year in the United States.

Asia Pacific is the most promising market for the growth of neonatal respiratory distress syndrome market as there are many developing regions that are growing at a steady pace. The major factors which will propel the growth of this market in Asia Pacific are high birth rate, increasing awareness related to the complications of respiratory distress syndrome in infants and increasing pregnancy-induced hypertension due to malnutrition. Moreover, increasing incidences of premature labor and high-risk pregnancy in mothers would drive the Asian market towards future growth.

Many pharmaceutical companies and clinical trial institutes are constantly trying to come up with novel therapeutic development for the treatment of neonatal respiratory distress syndrome. Some of the leading players operating in the neonatal respiratory distress market are Chiesi Farmaceutici SpA, Discovery Laboratories, Inc., Takeda Pharmaceutical Company Limited, Auckland City Hospital, Menzies Research Institute and many others.

View Report -

https://www.transparencymarketresearch.com/neonatal-respiratory-distress-syndrome.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.